2023 was a troublesome year with the biopharma field, with many organizations downsizing and restructuring their workforces to stay afloat. There are signs of Restoration, as mergers and acquisitions picked up across the pharmaceutical and life sciences marketplace inside the latter part of 2023 and have ongoing their upswing into https://sites.google.com/view/bio-sites/blog